Herbert Loong: Excellent multidisciplinary discussions on AYA Oncology

Herbert Loong shared a post on LinkedIn:

“Many thanks to my Duke-NUS Medical School National Cancer Centre Singapore colleagues for kind invite and hospitality to discuss role of immunotherapy in hereditary cancers at their 2nd Grand Round together with Eileen Poon and Nurse Diana from their genetics team. Excellent multidisciplinary discussions on AYA Oncology.”

Source: Herbert Loong/LinkedIn

More posts by Herbert Loong on oncodaily.com

Dr. Herbert H. F. Loong holds several prominent positions in oncology. He is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).

Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer.